On-demand

MRD Monitoring of AML - State of the Art

Accreditation points

1.5 Accreditation points

Type

Digital

Price

There is no personal contribution required for this program.

This webinar has been broadcasted live on June 16th and is now available on demand.

MRD testing plays an increasingly important role in monitoring and follow-up of various hematological disorders. In this webinar, we will discuss two main MRD techniques: flow cytometry MRD and molecular MRD. The development and implementation of these techniques vary across European countries.

This free-of-charge, live webinar aims to enhance the quality of MRD testing across the EU. The program features state-of-the-art lectures on flow cytometry MRD and molecular MRD. Additionally, we will discuss the implementation of MRD guidelines from both clinical and laboratory perspectives.

Program

Introduction

Go to section

Clinical Perspective Overview

Poll question 2

Flow Cytometry MRD – State of the Art

Poll question 3

Molecular MRD – State of the Art

Discussion on MRD Monitoring

Poll question 4

MRD Guidelines from a Laboratory Perspective

MRD Guidelines from a Clinical Perspective

Discussion on MRD guidelines

Final assessment

Speakers

Michael Heuser, MD

Hematologist, Chair ELN-David group

Speaker

Sylvie Freeman, PhD

Professor of ImmunoHaematology

Speaker

Peter Valk, PhD

Principal Investigator Hematology

Speaker

Francesco Buccisano, MD

Hematologist

Speaker

Jacqueline Cloos, PhD

Professor Translational Hematology

Speaker

Gert Ossenkoppele, MD

Hematologist em.

Moderator

Professional association

EHA

1.5 accreditation points

Target areas

1

Biomedical specialist

2

Hematologists

3

Oncologists

4

Nurse specialists in hematology

Sponsor